48 results on '"Wu Xikun"'
Search Results
2. Population Pharmacokinetics and Dosing Optimization of Norvancomycin for Chinese Patients with Community-Acquired Pneumonia.
3. Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B , high TCL1A expression, or over- expressed MYC/BCL-2
4. Dualmarker: a flexible toolset for exploratory analysis of combinatorial dual biomarkers for clinical efficacy
5. Continuous Additive Manufacturing of Hemp Yarn-Reinforced Biocomposites with Improved Impregnation Method
6. The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
7. Workflow-based systematic design of high throughput genome annotation
8. Abstract LB289: Longitudinal ctDNA levels and clinical outcomes of first-line (1L) tislelizumab (TIS) + chemotherapy (chemo) treatment for advanced non-small cell lung cancer (NSCLC) in the RATIONALE-304 and 307 studies
9. Fast Initial Rotor Position Estimation for IPMSM With Unipolar Sequence-Pulse Injection
10. Determination of Free Valproic Acid Concentration in 569 Clinical Samples by LC-MS/MS After Hollow Fiber Centrifugal Ultrafiltration Treatment
11. Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia?
12. Association of liver metastases, tumor microenvironment, and treatment outcomes in patients with urothelial bladder cancer treated with tislelizumab.
13. Therapeutic drug monitoring of free vancomycin concentration in practice: A new analytical technique based on the HFCF–UF sample separation method
14. Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes
15. A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
16. Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe
17. Inhibition of imrecoxib on mRNA and protein expression of CYP2C11 enzyme in rats
18. Abstract LB511: The combination of hyper-amplification and tumor mutational burden as a pan-cancer biomarker in patients treated with tislelizumab
19. A combined experimental-numerical approach for the development of bio-based composite by and for additive manufacturing
20. Therapeutic drug monitoring of free vancomycin concentration in practice: A new analytical technique based on the HFCF–UF sample separation method.
21. Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).
22. Fast Initial Rotor Position Estimation for IPMSM With Unipolar Sequence-Pulse Injection
23. Determination of Free Valproic Acid Concentration in 569 Clinical Samples by LC-MS/MS After Hollow Fiber Centrifugal Ultrafiltration Treatment
24. Offline Inductance Identification of IPMSM With Sequence-Pulse Injection
25. 360 Tumor-immune signatures associated with response or resistance to tislelizumab in patients with previously treated advanced hepatocellular carcinoma (HCC)
26. 362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma
27. CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy
28. CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy
29. 77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC)
30. 76 Potential mechanisms of resistance identified through analysis of multiple biomarkers in immune hot non-responders with non-small cell lung cancer (NSCLC) treated with tislelizumab
31. Immune- and tumor-intrinsic gene expression profiles of response or resistance to tislelizumab as monotherapy or in combination with chemotherapy in non-small cell lung cancer (NSCLC).
32. Regional and global changes in TCRαβ T cell repertoires in the gut are dependent upon the complexity of the enteric microflora
33. Magnetic Equivalent Circuit Framework for an Axial Flux Permanent Magnet Synchronous Machine
34. Off-line Stator Resistance Identification for PMSM with Pulse Signal Injection avoiding the Dead-time Effect
35. Mining viral protease data to extract cleavage knowledge
36. Searching for discrimination rules in protease proteolytic cleavage activity using genetic programming with a min-max scoring function
37. Corrigendum: Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
38. Magnetic Equivalent Circuit Framework for an Axial Flux Permanent Magnet Synchronous Machine
39. Off-line Stator Resistance Identification for PMSM with Pulse Signal Injection avoiding the Dead-time Effect
40. Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
41. Work ow-based systematic design of high throughput genome annotation
42. Genomic analysis of the causative agents of coccidiosis in domestic chickens
43. Genomic analysis of the causative agents of coccidiosis in domestic chickens
44. Design and Implementation of Jess based on Intelligent Diagnosis System Paper
45. Sequencing and analysis of chromosome 1 of Eimeria tenella reveals a unique segmental organization.
46. Sequencing and analysis of chromosome 1 of Eimeria tenella reveals a unique segmental organization
47. Clinical Efficacy and Safety of Vancomycin Based on Unbound Vancomycin Concentration Monitoring.
48. [Pharmacokinetic profiles of antifungal drugs during extracorporeal membrane oxygenation life support].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.